Education, Science, Technology, Innovation and Life
Open Access
Sign In

The Impact of ESG Performance in the Pharmaceutical Industry on Corporate Value under the Background of "Double Carbon"—Take Yunnan Baiyao as an Example

Download as PDF

DOI: 10.23977/accaf.2024.050307 | Downloads: 40 | Views: 648

Author(s)

Yifei Chen 1

Affiliation(s)

1 School of Accounting, Yunnan University of Finance and Economics, Kunming, Yunnan, China

Corresponding Author

Yifei Chen

ABSTRACT

With growing global focus on ESG issues and the "double carbon" goal, ESG performance in various industries, exemplified by Yunnan Baiyao in the pharmaceutical industry, has become an important factor for measuring enterprise sustainable development and comprehensive value. By sorting theories, analyzing ESG practices, and constructing an evaluation model, it reveals ESG's impact on corporate financial and non-financial value, and provides targeted suggestions for improving ESG performance and value in the "double carbon" era.

KEYWORDS

Double carbon; Pharmaceutical industry; ESG; Enterprise value; Yunnan Baiyao

CITE THIS PAPER

Yifei Chen, The Impact of ESG Performance in the Pharmaceutical Industry on Corporate Value under the Background of "Double Carbon"—Take Yunnan Baiyao as an Example. Accounting, Auditing and Finance (2024) Vol. 5: 49-55. DOI: http://dx.doi.org/10.23977/accaf.2024.050307.

REFERENCES

[1] Pan Fei, Wang Liang. Research on the Relationship between Environmental Protection Investment and Economic Performance of Enterprises [J]. New Accounting, 2015 (4): 6-11. 
[2] Tang Yongjun, Xia Li. Environmental investment, quality of environmental information disclosure and enterprise value [J]. Science and Technology Management Research, 2019, 39 (10): 256-264.
[3] Zhu Qingxiang, Guo Huan, Li Xiaoqing. Research on the influence mechanism of social responsibility performance on enterprise value: mediating role based on accounting conservatism [J]. Forecast, 2019, 38 (3): 52-57.
[4] He Xianjie, Xiao Tusheng, Chen Xinyuan. Corporate Social Responsibility Information Disclosure and Corporate Financing Constraints [J]. Financial Research, 2012, 38 (8): 60-71, 83.

Downloads: 10885
Visits: 141498

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.